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Radial access angiography and angioplasty has increased in popu-
larity worldwide due to its decrease of access site complications,
early patient mobility, patient comfort and lower costs. In a min-
ority of patients, radial artery occlusion and radial artery spasm
occurs. Because of the dual blood supply to the hand, radial artery
occlusion is not associated with major clinical sequelae but pre-
vention is important. Transradial coronary procedures may be
performed through the right or left radial artery approaches
(RRA and LRA, respectively). While most of the studies assessing
the feasibility of the transradial approach have been done through
the RRA, the LRA may offer certain anatomical and other advan-
tages. We present our short experience in coronary diagnostic and
interventional procedures using the LRA approach. In 1989 Lucien
Campeau reported the ﬁrst 100 cases of trans left radial coronary
angiograms. The advantages of LRA approach is that the dominant
hand is free, radial loops and subclavian tortuousities are lesser,
only one bifurcation to be negotiated unlike right (where two, i.e.,
subclavian and brachiocephalic are to be crossed), easier direct
access to left internal mammary artery and descending aorta,
lesser incidence of strokes. The traditional Cath Lab set up as
for femoral procedures was done and IV access was obtained in
the right forearm; the NIBP cuff was in the left leg and the pulse
oximeter probe in the left index ﬁnger. The left arm was kept
elevated using small pillows, adducted using a velcro strap with
the forearm kept supinated on or adjacent to left thigh. Vascular
access was achieved by the operator standing on the right side of
the patient (like left femoral puncture). The local anaesthetic used
was 1 ml of 2% lignocaine with 100 mg of nitroglycerine in an
insulin syringe. Transradial kits of Cordis or Terumo were used
and sheaths 5F, 6F and sometimes even 7F were introduced and
spasmolytic cocktail comprising of nicorandil 8 mg and heparin
5000 U (for PCI 7500U) was administered through the sheath.
Judkins, Amplatz, Tiger, and Kimny catheters along with Terumo
guide wire, could be used to cannulate the coronaries and grafts
(post CABG) and angiographies, angioplasties including with rota-
blation could be carried out successfully in a total of 2215 cases
from 01 April 2013 to 15 August 2015. Post procedure compression
was done with roller guaze and elastoplast. Trans (Left) radial
coronary interventions have a short learning curve and are patient
friendly.
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Background: Abdominal aortic aneurysm is a common entity in
India. The risk of rupture signiﬁcantly increases after attaining the
size of 5.5 cm. Surgery was previously the only modality of deﬁ-
nitive therapy. Endovascular aneurysm repair (EVAR) has now
become a less invasivemode of therapy. Studies showed improved
short term MACE with EVAR, though the long-term outcomes are
similar to open surgical approach. We here summarize the single
center outcome and feasibility of EVAR in India in recent years.
Objective: In this study, we assessed the feasibility, short and
intermediate outcome, and complications of EVAR in a tertiary
care hospital of Eastern India.
Materials and methods: We had 11 patients with abdominal aortic
aneurysm in last 2 year. Prominent male preponderance was
found, with 8 (72%) out of 11 were male. Eight out of them were
smoker, 7 patients were hypertensive. Three patients were dia-
betic. Out of 11, nine patients underwent EVAR and 1 opted for
open surgical repair. One patient refused any intervention.
Results: Per procedural evaluation of the groin and aorto-iliac
vessel was done by CT angiogram. EVAR was successful in all 9
patients (100%) with endovascular graft placement. Three patients
(33%) required aorto-iliac bifurcation stenting in addition to EVAR.
There was no signiﬁcant endoleak in any of the patients. One
patient developed moderate hematoma at the groin, which was
treated conservatively. There was no incidence of renal artery,
spinal cord or colonic ischemia. All of them are doing well on
follow-up both clinically and radiologically (USG/CT).
Conclusion: Our case series shows that abdominal EVAR is a
minimally invasive alternative tomajor open surgery for the repair
of abdominal aortic aneurysms (AAAs) that results in reduced
recovery time with minimal complication at high volume centers
in expert hands. As the sample size of our series was small, a larger
study will probably depict the exact clinical outcome with longer
follow-up.
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Introduction: It has been observed that several legitimate patients
who qualify for thrombolysis following acute MI and reach our
peripheral health care units within window period, do not receive
thrombolysis due to fear and apprehension of the possible adverse
effect of thrombolysis. In our tertiary care center, we gave those
patients intravenous Heparin and dual antiplatelets immediately
on FMC prior to primary PTCA.
Aim: To observe the effect of treatment on patency of the infarct
related artery at 90 min following hospital arrival with acute MI
and also TIMI ﬂow following PPCI.
Methods: It was a single center, single arm study. We included 110
patients presenting within 12 h of chest pain. We gave 5000 unit of
IV Heparin, 350 mg of soluble Aspirin and loading dose of Clopido-
grel (600 mg) or Prasugrel (60 mg) or Ticagrelor (180 mg) after ruling
out the contraindications and according to physician's choice. We
analyzed the change in ﬂow in IRA after 90 min following the
loading doses.We analyzed ST segment variation in these patients
along with the change in LVEF.
Result: CAG performed within 90 min of the hospital admission
revealed TIMI-III ﬂow in IRA in 81% of the patients with good
peripheral blush. The incidences of slow or no ﬂow were signiﬁ-
cantly reduced during the procedure, which is very signiﬁcant. We
also found a signiﬁcant resolution of ST segment elevation with
isoelectric ST segment inmany patients, indicating TIMI-III ﬂow in
IRA with good peripheral myocyte perfusion.
Discussion: Previous literature reveals the patency rate of
the IRA with Streptokinase and Tenecteplase are 32% and 63%,
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respectively. In comparison to that our study shows same or no
inferior outcomewhich proves the drug combination is as effective
as thrombolysis.
Conclusion: Inj. Heparin along with DAPT on FMC following acute
MI yields similar results as thrombolysis with signiﬁcant improve-
ment in TIMI ﬂow of the IRA and also signiﬁcant reduction of the
slow ﬂow, no ﬂow or other complications during PPCI.
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Background: Triple antiplatelet therapy (TAT) has been found to be
superior to dual antiplatelet therapy (DAT) in patients with acute
coronary syndromes undergoing percutaneous coronary interven-
tion (PCI) with drug-eluting stents (DES).
Methods: A prospective, double blinded, randomized study was
conducted in ACS patients undergoing PCI with DES and control
population without any coronary artery disease (CAD). ACS
patients were randomized into DAT group (DAT, aspirin + clopido-
grel) and TAT group (TAT, aspirin + clopidogrel + cilostazol).
Patients in the TAT group were given loading doses of 200 mg of
cilostazol peri-procedurally (within 6–12 h prior to the procedure to
1–2 h post-procedure) followed by 100 mg/day for atleast six
months. Patients were evaluated at baseline, at seven days and
six months intervals for clinical outcomes. ADP, collagen, and
epinephrine-induced platelet aggregation was measured at base-
line and at seven days interval.
Results: There were no signiﬁcant differences in the baseline
characteristics in both the groups. Comparison between dual
and triple antiplatelet groups showed signiﬁcantly greater inhibi-
tion of ADP-induced platelet aggregation in the triple therapy
group at seven days interval (19.05  14.06% vs 36.20  25.0%,
p = 0.02) and trend towards greater platelet inhibition at baseline
between two groups (19.2  27.32% vs 33.0  22.01%, p = 0.077),
respectively. Triple therapy group had lesser number of patients
who had hyporesposiveness to antiplatelet therapy (deﬁned as
inhibition of less than 50% of ADP, collagen or epinephrine induced
platelet aggregation). The study was underpowered for assessing
MACE outcomes.
Conclusions: Cilostazol is a signiﬁcant add on therapy to standard
DAT with aspirin and high maintenance dose clopidogrel. Its
loading dose of 200 mg, followed by 100 mg BD provides greater
inhibition of ADP-induced platelet aggregation without increase in
bleeding complications or tolerance issues.
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The objective of this study is to evaluate outcome of the 20 patients
who underwent alcoholic septal ablation for symptomatic HOCM
at our hospital.
Background: LVOT obstruction is an important determinant of
clinical symptoms in patients with HOCM. Alcohol septal ablation
shown to decrease LVOT gradient and resolution of symptoms
immediately after the procedure and on midterm follow-up.
Methods: 20 patients with HOCM who underwent alcoholic septal
ablation at our hospital and completed one-year follow-up are
described. A detailed analysis of clinical examination and Echo
Doppler carried out.
Results: The mean age of the study group was 54  16 years (range
26–76 yrs). All patients had refractory symptoms before enrolment.
90% patients had NYHA class III/IV symptoms at baseline com-
pared to none at 1 year. Only 20% of patients were either receiving
beta-blockers or CCBs on follow-up. The resting LVOT gradient
decreased from 70  20 mmHg to 10  6 mmHg. These changes are
associated with decreased septal thickness and preserved systolic
function. Three patients (15%) developed complete heart block,
two patients improved after TPI and one required permanent
pacemaker. One patient (5%) developed acute anterior wall myo-
cardial infarction and taken for emergency CABG, but died during
post-operatively.
Conclusion: Alcohol septal ablation associated with decreased
septal thickness and preserved systolic function. This procedure
is an effective therapeutic procedure with favorable outcome.
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One hundred patients who underwent PCI with Yukon Choice Flex
(Indigenous stent) between September 2014 to February 2015 have
been studied retrospectively. There were 86 (86%) males and 14
(14%) females with mean age 59.12  12.33 (28–84 years). Risk
factors were hypertension – 50(50%), type 2 DM – 42(42%), smoking
28(28%), CKD 8(8%), and dyslipidemia 14 (14%). Clinical presenta-
tion was ACS with STEMI – 44 (44%), NSTEMI 30 (30%), unstable
angina – 14 (14%). Chronic stable angina was present in 12 (12%)
patients. Mean LVEF of this group was 50.3  9.3% (range 21–60%).
Three patients with STEMI presented in cardiogenic shock.
Coronary angio proﬁle revealed single vessel disease in 54 (54%)
and multi-vessel disease in 46 (46%) patients. PCI was done
through femoral artery in 80 (80%) and right radial in 20 (20%)
patients. Weight adjusted heparin was used as anticoagulant.
Antiplatelet therapy in the form of asprin, clopidogrel, or prasugrel
was used in patients at operators discretion.
Primary angioplasty was done in 16 (16%) patients. IABP support
was used in 6 (6%). GP IIb/IIIa inhibitors were used in 76 (76%)
patients, of which 52 (66%) received tiroﬁban, while 26 (34%)
received abciximab.
All patients received biodegradable polymer sirolimus eluting
Yukon Choice Flex stent. Average stent diameter was 2.92
 0.44 mm. Average stent length was 24.53  8.47 mm. Average
no. of stents deployed per patient was 1.66  0.86. Average dura-
tion of hospital stay was 3  1.31 days. One patient who was in
cardiogenic shock died during the hospital stay. There was no
other MACE during the hospitalization. Two patients were
admitted with subacute stent thrombosis at 7 and 20 days,
requiring re-dilatation. Patients were followed clinically and
telephonically between 6 and 9 months (mean 8.23  7.03
months).
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